Chronic hypoxia modulates endothelium-dependent vasorelaxation through multiple independent mechanisms in ovine cranial arteries

Advances in Experimental Medicine and Biology

Volumn 578, Issue , 2006, Pages 87-92

  Pearce, William J ^a   Williams, James M ^a   Hamade, Mohammad W ^a   Chang, Melody M ^a   White, Charles R ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934438444     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-29540-2_14     Document Type: Conference Paper

References (28)

1. M. L. Fung, Hypoxia-inducible factor-1: a molecular hint of physiological changes in the carotid body during long-term hypoxemia?, Curr Drug Targets Cardiovasc Haematol Disord 3(3), 254-9 (2003).
2. C. Fradette and P. Du Souich, Effect of hypoxia on cytochrome P450 activity and expression, Curr Drug Metab 5(3), 257-71 (2004).
3. L. G. Moore, M. Shriver, L. Bemis, B. Hickler, M. Wilson, T. Brutsaert, E. Parra and E. Vargas, Maternal adaptation to high-altitude pregnancy: an experiment of nature - a review, Placenta 25( Suppl A), S60-71 (2004).
4. C. Peers and P. J. Kemp, Ion channel regulation by chronic hypoxia in models of acute oxygen sensing, Cell Calcium 36(3-4), 341-8 (2004).
5. C. A. Raguso, S. L. Guinot, J. P. Janssens, B. Kayser and C. Pichard, Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude, Curr Opin Clin Nutr Metab Care 7(4), 411-7 (2004).
6. J. T. Reeves and F. Leon-Velarde, Chronic mountain sickness: recent studies of the relationship between hemoglobin concentration and oxygen transport, High Alt Med Biol 5(2), 147-55 (2004).
7. L. D. Longo, A. D. Hull, D. M. Long and W. J. Pearce, Cerebrovascular adaptations to high-altitude hypoxemia in fetal and adult sheep, Am J Physiol 264(1), R65-72 (1993).
8. N. Ueno, Y. Zhao, L. Zhang and L. D. Longo, High altitude-induced changes in alpha1-adrenergic receptors and Ins(1,4,5)P3 responses in cerebral arteries, Am J Physiol 272(2), R669-74 (1997).
9. J. Buchholz, K. Edwards-Teunissen and S. P. Duckles, Impact of development and chronic hypoxia on NE release from adrenergic nerves in sheep arteries, Am J Physiol 276(3), R799-808 (1999).
10. W. J. Pearce, Mechanisms of hypoxic cerebral vasodilatation, Pharmacol Ther 65(1), 75-91 (1995).
11. J. M. Marshall, Adenosine and muscle vasodilatation in acute systemic hypoxia, Acta Physiol Scand 168(4), 561-73 (2000).
12. W. J. Pearce, S. Ashwal and J. Cuevas, Direct effects of graded hypoxia on intact and denuded rabbit cranial arteries, Am J Physiol 257(3), H824-33 (1989).
13. G. Q. Teng, J. Williams, L. Zhang, R. Purdy and W. J. Pearce, Effects of maturation, artery size, and chronic hypoxia on 5-HT receptor type in ovine cranial arteries, Am J Physiol 275(3), R742-53 (1998).
14. H. Taniguchi, Y. Tanaka, H. Hirano, H. Tanaka and K. Shigenobu, Evidence for a contribution of storeoperated Ca2+ channels to NO-mediated endothelium-dependent relaxation of guinea-pig aorta in response to a Ca2+ ionophore, A23187, Naunyn Schmiedebergs Arch Pharmacol 360(1), 69-79 (1999).
15. J. M. Williams, A. D. Hull and W. J. Pearce, Maturational Modulation of Endothelium-Dependent Vasodilatation in Ovine Cerebral Arteries, Am J Physiol Regul Integr Comp Physiol 288(1), R149-57 (2004).
16. D. J. Kleinhenz, X. Fan, J. Rubin and C. M. Hart, Detection of endothelial nitric oxide release with the 2,3-diaminonapthalene assay, Free Radic Biol Med 34(7), 856-61 (2003).
17. Y. C. Boo and H. Jo, Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases, Am J Physiol Cell Physiol 285(3), C499-508 (2003).
18. I. Fleming and R. Busse, Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase, Am J Physiol Regul Integr Comp Physiol 284(1), R1-12 (2003).
19. R. D. Minshall, W. C. Sessa, R. V. Stan, R. G. Anderson and A. B. Malik, Caveolin regulation of endothelial function, Am J Physiol Lung Cell Mol Physiol 285(6), L1179-83 (2003).
20. J. Garthwaite, E. Southam, C. L. Boulton, E. B. Nielsen, K. Schmidt and B. Mayer, Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Mol Pharmacol 48(2), 184-8 (1995).
21. C. R. White, X. Hao and W. J. Pearce, Maturational differences in soluble guanylate cyclase activity in ovine carotid and cerebral arteries, Pediatr Res 47(3), 369-75 (2000).
22. M. Russwurm and D. Koesling, Isoforms of NO-sensitive guanylyl cyclase, Mol Cell Biochem 230(1-2), 159-64 (2002).
23. D. Koesling and A. Friebe, Soluble guanylyl cyclase: structure and regulation, Rev Physiol Biochem Pharmacol 135(1), 41-65 (1999).
24. S. Andreopoulos and A. Papapetropoulos, Molecular aspects of soluble guanylyl cyclase regulation, Gen Pharmacol 34(3), 147-57 (2000).
25. T. Matsumoto, T. Kobayashi and K. Kamata, Phosphodiesterases in the vascular system, J Smooth Muscle Res 39(4), 67-86 (2003).
26. S. D. Rybalkin, C. Yan, K. E. Bornfeldt and J. A. Beavo, Cyclic GMP phosphodiesterases and regulation of smooth muscle function, Circ Res 93(4), 280-91 (2003).
27. S. H. Francis, I. V. Turko and J. D. Corbin, Cyclic nucleotide phosphodiesterases: relating structure and function, Prog Nucleic Acid Res Mol Biol 65(1), 1-52 (2001).
28. C. R. White and W. J. Pearce, Effects of maturation on cyclic GMP metabolism in ovine carotid arteries, Pediatr Res 39(1), 25-31 (1996).